CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

RemedyRepack Inc. recalls Carvedilol 25 mg Tablet

Read the official FDA notice

Published
12 Feb 2025
Units affected
247 blister packs
Agency
FDA
Country
United States

The hazard

CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Carvedilol 25 mg Tablet, QTY: 30 Tablets per Blister Pack (3 x 10 blister cards), Rx Only, MFG by: Glenmark, Mahwah, NJ 07430, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC: 70518-3945-00.

Brand / company
RemedyRepack Inc.
Codes / lots
Lot #s: J0777493050824, Exp. 5/31/2025; J0787856062124, Exp. 7/31/2025.
Distribution
FL
Recall status
Terminated

Source: U.S. Food and Drug Administration, published 12 Feb 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.